Role of Acute Exercise Modality on Appetite Regulation and Energy Intake

June 3, 2019 updated by: University of Colorado, Denver

This study plans to learn more about how type of exercise influences measures of appetite regulation. In this study, investigators will be evaluating a resistance exercise session (using weight machines and free weights) and an aerobic exercise session (using a treadmill). Participants will also complete a sedentary control condition.

A secondary purpose is to compare sex-based differences in appetite-indices in response to exercise. Therefore, the responses to aerobic and resistance exercise will also be compared between men and women.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

38

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Colorado
      • Aurora, Colorado, United States, 80045
        • University of Colorado Denver - Anschutz Medical Campus

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 55 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • All ethnic groups and both genders
  • Age: 18-55 yrs (changed in September 2018 because trial we are modeling enrollment criteria on [NCT02047721] changed age range, so we adjusted for this trial as well)
  • BMI: 18.5-40 kg/m2 (changed in June 2018 from original range of 27-35 kg/m2 in order to improve recruitment. This is because recruitment within our prior BMI range had been slower than anticipated and potential participants that have expressed interest have screened out because of this. Given that we are still limiting enrollment criteria to adults who are inactive, it is likely that most will have body fat levels above normative standards, and therefore still be classified as having excess adiposity, even if their BMI is below 25 kg/m2. Furthermore, given the pilot nature of this work we believe it is important to complete the trial in a timely manner. We anticipate alterations to the enrollment criteria helping with this effort.)
  • Weight stable within ±5% in the last 6 months
  • Physically inactive (not meeting current physical activity guidelines, by self-report, no resistance training in previous 12-months)

Exclusion Criteria:

  • History of cardiovascular disease (CVD), diabetes mellitus, uncontrolled hypertension (defined as: systolic blood pressure >160 mmHg or diastolic blood pressure >100mmHg, as measured during the screening visit with participants seated quietly, following established guidelines39), renal disease (e.g. chronic kidney disease, polycystic kidney disease, nephritis, etc.), hepatic disease (e.g. cirrhosis, liver failure, fatty liver, jaundice, etc.), untreated thyroid disease (e.g. Grave's disease, Hashimoto's disorder, goiters, thyroid cancers, etc.), or any other medical condition affecting weight or energy metabolism. Participants who are deemed ineligible based upon uncontrolled hypertension criteria will be referred to their primary care physicians for treatment. If this conditions become controlled they will be allowed to be re-evaluated for inclusion in the current trial.
  • Symptoms suggestive of CVD: chest pain, shortness of breath at rest or with mild exertion, syncope.
  • Unable to exercise due to cardiac, pulmonary, neurologic or orthopedic reasons.
  • Significant gastrointestinal disorders including: inflammatory bowel disease requiring treatment within the past year, chronic malabsorptive conditions, chronic diarrhea, or active gallbladder disease.
  • Currently smoking and/or nicotine use within the past 6 months.
  • Treatment with medications known to significantly affecting appetite, weight, energy metabolism, energy intake or energy expenditure in the last 6 months (e.g. systemic corticosteroids, appetite suppressants, lithium, stimulants, anti-psychotics, tricyclic antidepressants).
  • Weight loss or weight gain of >5% in past 6 months.
  • History of surgical procedure for weight loss at any time (e.g. gastroplasty, gastric bypass, gastrectomy or partial gastrectomy, adjustable banding, gastric sleeve); history of extensive bowel resection for other reasons.
  • Currently pregnant (confirmed via urine pregnancy test), lactating or less than 6 months post-partum.
  • Self-report of alcohol or substance abuse within the past 12 months.
  • History of clinically diagnosed eating disorders including anorexia nervosa, bulimia, binge eating disorder, or score >20 on the EATS-26. Participants with a score >20 on the EATS-26 will be referred to their primary care physician for further evaluation.
  • Major psychiatric disorder (e.g. diagnosis of schizophrenia, bipolar disorder, or other psychotic disorders).
  • Current severe depression or history of severe depression within the previous year (based on reported history, study physician examination findings, and/or a score >21 on the CES-D). Participants meeting any of these criteria will be referred to their primary care physician and/or the emergency department (based upon study physician determined level of severity).
  • Significant food intolerances/allergies that cannot be accommodated by the CTRC Metabolic Kitchen.
  • Currently participating in or planning to participate in any formal weight loss or physical activity programs or clinical trials.
  • Other medical, psychiatric, or behavioral limitations that may interfere with participation (as determined by study physician).
  • Unable or unwilling to undergo study procedures
  • Women who are peri- or post-menopausal, or report irregular menstrual cycles.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Aerobic Exercise
The overall aim of this study is to compare how acute exercise modality (e.g. resistance exercise vs. aerobic exercise) differentially influence hormonal and behavioral indices of appetite regulation and ad libitum energy intake. Both conditions will also be compared to a non-exercise control condition.
Experimental: Resistance Exercise
The overall aim of this study is to compare how acute exercise modality (e.g. resistance exercise vs. aerobic exercise) differentially influence hormonal and behavioral indices of appetite regulation and ad libitum energy intake. Both conditions will also be compared to a non-exercise control condition.
Placebo Comparator: No Exercise
The overall aim of this study is to compare how acute exercise modality (e.g. resistance exercise vs. aerobic exercise) differentially influence hormonal and behavioral indices of appetite regulation and ad libitum energy intake. Both conditions will also be compared to a non-exercise control condition.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Ghrelin Area Under the Curve (AUC)
Time Frame: At baseline and every 30 minutes for 3 hours following a breakfast meal
Concentration of ghrelin values, overtime for each arm of the study
At baseline and every 30 minutes for 3 hours following a breakfast meal
Change in Peptide YY (PYY) AUC
Time Frame: At baseline and every 30 minutes for 3 hours following a breakfast meal
Concentration of PYY values, overtime for each arm of the study
At baseline and every 30 minutes for 3 hours following a breakfast meal
Change in GLP-1 AUC
Time Frame: At baseline and every 30 minutes for 3 hours following a breakfast meal
Concentration of GLP-1 values, overtime for each arm of the study. Added in December 2017 following receipt of additional funding to add this measure)
At baseline and every 30 minutes for 3 hours following a breakfast meal

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Hunger AUC
Time Frame: At baseline and every 30 minutes for 3 hours following a breakfast meal
Subjective indicator of hunger values, overtime for each arm of the study. Evaluated via 100 mm visual analogue scales
At baseline and every 30 minutes for 3 hours following a breakfast meal
Change in Satiety AUC
Time Frame: At baseline and every 30 minutes for 3 hours following a breakfast meal
Subjective indicator of satiety values, overtime for each arm of the study. Evaluated via 100 mm visual analogue scales
At baseline and every 30 minutes for 3 hours following a breakfast meal
Change in Prospective Food Consumption AUC
Time Frame: At baseline and every 30 minutes for 3 hours following a breakfast meal
Subjective indicator of prospective food consumption values, overtime for each arm of the study. Evaluated via 100 mm visual analogue scales
At baseline and every 30 minutes for 3 hours following a breakfast meal
Change in Ad libitum Energy Intake - in lab
Time Frame: 3 hours following breakfast meal on each arm
In lab ad libitum buffet lunch (via weigh and measure methodology) at the end of each study arm visit
3 hours following breakfast meal on each arm
Change in Ad libitum Energy Intake - free living
Time Frame: For 3 days following each arm
3 days of free-living ad libitum energy intake (via self-report)
For 3 days following each arm

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Difference Between Men and Women in Appetite-Indices
Time Frame: At baseline, every 30 minutes for 3 hours following a breakfast meal, and for 3 days following each arm
Sex-Based Differences (Added in December 2017 following receipt of additional funding to increase sample size for this purpose)
At baseline, every 30 minutes for 3 hours following a breakfast meal, and for 3 days following each arm
Difference in Behavioral Economics Constructs (Delayed Discounting and Hypothetical Purchase Task)
Time Frame: In the fed state, following completion of assigned exercise bout (or control bout).
Delayed Discounting to evaluate value of future outcomes. Hypothetical Purchase Task to evaluate value of food. (Added in December 2017 following meeting with a colleague interested in adding these measures)
In the fed state, following completion of assigned exercise bout (or control bout).

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Tanya M Halliday, PhD, RD, University of Colorado, Denver

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 14, 2017

Primary Completion (Actual)

June 3, 2019

Study Completion (Actual)

June 3, 2019

Study Registration Dates

First Submitted

May 2, 2017

First Submitted That Met QC Criteria

May 3, 2017

First Posted (Actual)

May 8, 2017

Study Record Updates

Last Update Posted (Actual)

June 4, 2019

Last Update Submitted That Met QC Criteria

June 3, 2019

Last Verified

June 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • 16-2697
  • UL1TR001082-04 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Appetite Regulation

Clinical Trials on Exercise Modality

3
Subscribe